The binding risk is validation: translating roadmap claims into externally credible, repeatable capability that customers pay for at scale. The second risk is financing and
dilution across a long R&D cycle, potentially worsened by a capital- and execution-heavy
foundry integration. Finally, value capture could be weaker than hoped if quantum access becomes multi-vendor, agent-routed, and price-compared—forcing IonQ into lower-margin services or partner-controlled channels.